openPR Logo
Press release

Chagas Disease (American Trypanosomiasis) Market, Growth, Sales -Pipeline Review, H2 Research Reports 2017 Tag:- Chagas Disease,

11-03-2017 06:30 AM CET | Health & Medicine

Press release from: Market Research Hub

Market Research Hub

Market Research Hub

To Understand the pharmaceutical Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Chagas Disease (American Trypanosomiasis)-Pipeline Review, H2 2017” to its vast database. This study offers data about the prime regions operating in the pharmaceutical sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR until 2022.

Request For Free Sample Report: https://www.marketresearchhub.com/enquiry.php?type=S&repid=1361392

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease (American Trypanosomiasis)-Pipeline Review, H2 2017, provides an overview of the Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline landscape.

Chagas disease or American Trypanosomiasis is a vector-borne anthropozoonosis caused by the protozoan parasite Trypanosoma cruzi. Symptoms include swelling at the infection site, fever, fatigue, body aches, loss of appetite, nausea, diarrhea or vomiting and swollen glands. Treatment includes antiparasitic medications. 

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Chagas Disease (American Trypanosomiasis)-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Chagas Disease (American Trypanosomiasis) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chagas Disease (American Trypanosomiasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 3, 1, 3 and 6 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 18 and 6 molecules, respectively.

Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Chagas Disease (American Trypanosomiasis) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Chagas Disease (American Trypanosomiasis) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Chagas Disease (American Trypanosomiasis) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Chagas Disease (American Trypanosomiasis) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 
- The pipeline guide reviews latest news related to pipeline therapeutics for Chagas Disease (American Trypanosomiasis) (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Chagas Disease (American Trypanosomiasis) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Browse Full Report with TOC: https://www.marketresearchhub.com/report/chagas-disease-american-trypanosomiasis-pipeline-review-h2-2017-report.html

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Chagas Disease (American Trypanosomiasis)-Overview 6
Chagas Disease (American Trypanosomiasis)-Therapeutics Development 7
Pipeline Overview 7
Pipeline by Companies 8
Pipeline by Universities/Institutes 10
Products under Development by Companies 12
Products under Development by Universities/Institutes 13
Chagas Disease (American Trypanosomiasis)-Therapeutics Assessment 15
Assessment by Target 15
Assessment by Mechanism of Action 17
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Chagas Disease (American Trypanosomiasis)-Companies Involved in Therapeutics Development 23
AstraZeneca Plc 23
Bayer AG 23
Daiichi Sankyo Co Ltd 24
Eisai Co Ltd 24
GlaxoSmithKline Plc 25
Grupo Praxis Pharmaceutical SA 25
Humanigen Inc 26
Kancera AB 26
Merck & Co Inc 27
Novartis AG 27
Oblita Therapeutics BVBA 28
Sanofi 28
Chagas Disease (American Trypanosomiasis)-Drug Profiles 29
benznidazole-Drug Profile 29
benznidazole-Drug Profile 30
chagas disease (bivalent) vaccine-Drug Profile 31
chagas disease vaccine-Drug Profile 32
chagas disease vaccine-Drug Profile 33
Chagas disease vaccine-Drug Profile 34
Chagas disease vaccine 2-Drug Profile 35
Cz-007-Drug Profile 36
Cz-008-Drug Profile 37
D-121-Drug Profile 38
DNDI-0690-Drug Profile 40
EPLBS-1246-Drug Profile 41
EPLBS-967-Drug Profile 42
fexinidazole-Drug Profile 43
fosravuconazole-Drug Profile 45
GNF-6702-Drug Profile 47
K-777-Drug Profile 48
KAN-0441411-Drug Profile 50
MAO-1-Drug Profile 51
NEU-321-Drug Profile 52
nifurtimox-Drug Profile 53
SAR-114137-Drug Profile 54
Small Molecule for Chagas Disease-Drug Profile 55
Small Molecule to Inhibit SOD for Chagas Disease and Leishmaniasis-Drug Profile 56
Small Molecules for Chagas Disease-Drug Profile 57
Small Molecules for Chagas Disease-Drug Profile 58
Small Molecules for Chagas Disease-Drug Profile 59
Small Molecules for Chagas Disease-Drug Profile 60
Small Molecules for Infectious Diseases-Drug Profile 61
Small Molecules for Infectious Diseases-Drug Profile 62
Small Molecules for Leishmaniasis and Chagas Disease-Drug Profile 63
Small Molecules for Trypanosomiasis-Drug Profile 64
Small Molecules to Inhibit Cruzipain for Chagas Disease-Drug Profile 65
Small Molecules to Inhibit Cruzipain for Chagas Disease-Drug Profile 66
Small Molecules to Inhibit CYP51A1 for Chagas Disease-Drug Profile 67
Small Molecules to Inhibit Lanosterol 14 alpha-Demethylase for Chagas Disease, Leishmaniasis and African Trypanosomiasis-Drug Profile 68
Small Molecules to Inhibit Proline Racemase for Chagas Disease-Drug Profile 69
VNI-Drug Profile 70
Chagas Disease (American Trypanosomiasis)-Dormant Projects 71
Chagas Disease (American Trypanosomiasis)-Discontinued Products 72
Chagas Disease (American Trypanosomiasis)-Product Development Milestones 73
Featured News & Press Releases 73
Appendix 84
Methodology 84

Continued….

Enquire About This Report: https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1361392

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States

Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chagas Disease (American Trypanosomiasis) Market, Growth, Sales -Pipeline Review, H2 Research Reports 2017 Tag:- Chagas Disease, here

News-ID: 799666 • Views:

More Releases from Market Research Hub

Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, Leading Players : DEWALT, Shark,Benchmark Abrasives,Bosch,Hot Max Up to 2025
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, Stiplastics S.A.S, Argo S.A, Gramb GmbH Kunststoffverarbeitung, Origin Pharma Packaging, Eastman Chemical Company, Yuyao Liantong Plastic & Mould Co., Ltd
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstock, MingYue, Conant, Wanxin, CHEMI, Nikon
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the

All 5 Releases


More Releases for Disease

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and